TARA
Protara Therapeutics Inc
3.40$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.8% | -13.7% | +49.2% | -7.4% | +92.9% | -7.1% | -6.9% | -7.8% | +44.8% | -8.4% | -8.2% | |
| – | -11.7% | -15.7% | +59.2% | -7.7% | +102.3% | -26.5% | -1.1% | +8.4% | +17.6% | -12.2% | +4.4% | |
| – | +17.2% | +31.9% | +71.5% | -42.2% | +214.5% | -43.8% | -65.6% | -60.2% | +295.6% | -70.3% | +15.9% | |
| – | -11.4% | -15.8% | +62.2% | -9.0% | +108.9% | -27.0% | -1.7% | +8.6% | +17.2% | -12.7% | -87.4% | |
| – | -13.3% | -90.5% | – | – | – | – | +141.8% | +12.5% | +25.6% | +20.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -1.4% | -1.7% | -1.6% | +27.8% | -4.1% | -2.4% | -1.6% | -2.0% | +101.5% | -1.0% | |
| – | -7.6% | -8.5% | -1.3% | +28.2% | +16.4% | -29.6% | +24.2% | -1.3% | +5.8% | -17.9% | +38.0% | |
| – | -9.2% | -10.5% | +2.7% | +53.0% | +26.8% | -36.0% | +39.1% | +1.5% | +10.4% | -18.4% | +49.3% | |
| – | +1.8% | +1.7% | +3.5% | +4.3% | +4.2% | +4.1% | +2.5% | +1.8% | +1.8% | +1.8% | +1.7% | |
| – | -2.8% | -60.1% | +42.5% | +65.7% | +93.0% | -47.8% | +129.4% | -15.0% | -23.0% | +16.2% | +15.7% | |
| – | -11.2% | -14.5% | +57.6% | -11.1% | +104.3% | -5.2% | -8.9% | -8.4% | +48.5% | -7.7% | -11.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.5% | +85.9% | +5.2% | +18.4% | +54.0% | +3.8% | +0.0% | +8.9% | +25.0% | +6.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.